Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 8,900 shares at $15.00 ($135K) on 2007-12-05, disclosed to the SEC on 2007-12-06.
Scheduled sale ($135k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.98 | 200 | $3K | 2.2% |
| 2 | $14.99 | 200 | $3K | 2.2% |
| 3 | $15.00 | 200 | $3K | 2.2% |
| 4 | $15.01 | 200 | $3K | 2.2% |
| 5 | $15.02 | 600 | $9K | 6.7% |
| 6 | $15.03 | 300 |
| $5K |
| 3.3% |
| 7 | $15.04 | 200 | $3K | 2.2% |
| 8 | $15.05 | 300 | $5K | 3.3% |
| 9 | $15.08 | 200 | $3K | 2.2% |
| 10 | $15.09 | 400 | $6K | 4.5% |
| 11 | $15.10 | 200 | $3K | 2.2% |
| 12 | $15.15 | 800 | $12K | 9.0% |
| 13 | $15.16 | 500 | $8K | 5.6% |
| 14 | $15.17 | 700 | $11K | 7.9% |
| 15 | $15.18 | 300 | $5K | 3.4% |
| 16 | $15.20 | 200 | $3K | 2.3% |
| 17 | $15.21 | 100 | $2K | 1.1% |
| 18 | $15.22 | 200 | $3K | 2.3% |
| 19 | $15.23 | 200 | $3K | 2.3% |
| 20 | $15.24 | 200 | $3K | 2.3% |
| 21 | $15.26 | 200 | $3K | 2.3% |
| 22 | $15.28 | 100 | $2K | 1.1% |
| 23 | $15.30 | 100 | $2K | 1.1% |
| 24 | $15.31 | 700 | $11K | 7.9% |
| 25 | $15.32 | 500 | $8K | 5.7% |
| 26 | $15.33 | 100 | $2K | 1.1% |
| 27 | $15.36 | 240 | $4K | 2.7% |
| 28 | $15.37 | 460 | $7K | 5.2% |
| 29 | $15.40 | 200 | $3K | 2.3% |
| 30 | $15.42 | 100 | $2K | 1.1% |
| Total | $15.18 avg | 8,900 | $135K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |